Eugia US LLC recalls 400 mg per 10 mL Triamcinolone Acetonide Injectable Suspension vials due to glass particles found in some units. This may cause injury during injection. Affected vials have NDC 55150-385-01 and were manufactured in India for Auromedics Pharma LLC.
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Take action
Contact the company
📍Recalling firmEugia US LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
“Eugia Triamcinolone Vial Recall: Glass Particles Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33093-eugia-triamcinolone-vial-recall-glass-particles-risk. Based on FDA recall #D-0041-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0041-2024%22&limit=1).
Eugia US LLC recalled Triamcinolone Acetonide Injectable Suspension, USP due to the presence of particulate matter, according to the FDA. The Food and Drug Administration announced the recall on September 28, 2023.
How to tell if you have it
Brand: Eugia
Product: Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial
NDC: 55150-385-01
Lot #: 3TC22010
Expiration Date: 11/30/2024
The hazard
A product complaint identified a piece of glass, roughly 1 cm x 0.5 cm, inside a vial. The record states the hazard is the presence of particulate matter.
Context
GovInfoNow's records show Eugia US LLC has 14 other recalls on record since December 28, 2022. Other recent recalls include an August 10, 2026 Fresenius Kabi Tyenne Injection recall for glass particles, a May 12, 2026 Sun Pharmaceutical DOXOrubin Liposome Injection recall for glass particulate risk, and an August 6, 2026 Mallinckrodt Acthar Gel 5mL Vial recall for particulate matter hazard.
How to tell if you have this one
Check for vials labeled 'Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial'. The NDC number is 55150-385-01 and was manufactured in India for Auromedics Pharma LLC.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for the NDC number 55150-385-01 on the vial label.
Stop Using Vial
If you have the recalled vial, do not use it for injections.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 13 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0041-2024 (September 28, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0041-2024 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.